Coronary Keynote Lecture: Evidence-Based Contemporary Options for Treatment of In-Stent Restenosis
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Ancora Heart USA